非肌层浸润性膀胱癌根治性膀胱切除术中淋巴结清扫的作用:多中心经验
多中心回顾性分析1647例接受根治性膀胱切除术的非肌层浸润性膀胱癌患者,中位淋巴结产出15枚。模型提示淋巴结产出10枚和20枚分别优化局部盆腔无复发生存和癌症特异性生存/总生存;淋巴结产出>10枚与较低局部盆腔复发风险相关,>20枚与更好的癌症特异性生存和总生存相关。
要点
- 根治性膀胱切除术中更广泛的淋巴结清扫与非肌层浸润性膀胱癌患者更好的局部盆腔无复发生存、癌症特异性生存和总生存相关。
- 淋巴结产出>10枚与局部盆腔复发风险降低相关,>20枚与癌症特异性生存和总生存改善相关。
- 在cT1和cTis亚组中观察到相似结果,支持在这类患者中纳入淋巴结清扫。
核心结论
- 非肌层浸润性膀胱癌根治性膀胱切除术中更广泛的淋巴结清扫与局部盆腔无复发生存、癌症特异性生存和总生存改善相关。
研究设计与样本
- 多中心回顾性综述,纳入3家大型三级转诊中心接受根治性膀胱切除术的非肌层浸润性膀胱癌患者,共1647例,中位淋巴结产出15枚(四分位数9,23)。
主要发现
- 模型性能曲线提示淋巴结产出10枚和20枚分别优化局部盆腔无复发生存和癌症特异性生存/总生存。
- 多变量回归显示,与淋巴结产出≤10枚相比,>10枚与局部盆腔复发风险降低相关(HR 0.63,95%CI 0.42-0.93,p=0.02)。
- 与淋巴结产出≤20枚相比,>20枚与癌症特异性生存改善相关(HR 0.67,95%CI 0.52-0.87,p=0.002)和总生存改善相关(HR 0.75,95%CI 0.64-0.88,p<0.001)。
- 在cT1和cTis亚组中观察到相似结果。
临床怎么用
- 支持在非肌层浸润性膀胱癌根治性膀胱切除术中纳入淋巴结清扫,尤其是cTis或cT1疾病患者。
局限性
- 未来需要前瞻性研究评估非肌层浸润性膀胱癌中淋巴结清扫的理想解剖模板。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: While lymph node dissection (LND) at radical cystectomy (RC) for muscle-invasive bladder cancer has been studied extensively, the role of LND for nonmuscle-invasive bladder cancer (NMIBC) remains incompletely defined. Herein, we aim to assess the association between extent of LND during RC for NMIBC and local pelvic recurrence-free survival (LPRS), cancer-specific survival (CSS) and overall survival (OS). MATERIALS AND METHODS: A multi-institutional retrospective review was performed of patients with NMIBC undergoing RC at 3 large tertiary referral centers. To identify a threshold for lymph node yield (LNY) to optimize LPRS, CSS and OS, separate Cox regression models were developed for each possible LNY threshold. Model performance including Q-statistics and hazard ratios (HRs) were used to identify optimal LNY thresholds. RESULTS: A total of 1,647 patients underwent RC for NMIBC, with a median LNY of 15 (quartiles 9,23). Model performance curves suggested LNY of 10 and 20 to optimize LPRS and CSS/OS, respectively. On multivariable regression, LNY >10 was associated with lower risk of LPR compared to LNY ≤10 (HR 0.63, 95% CI 0.42-0.93, p=0.02). Similarly, LNY >20 was associated with improved CSS (HR 0.67, 95% CI 0.52-0.87, p=0.002) and OS (HR 0.75, 95% CI 0.64-0.88, p <0.001) compared to LNY ≤20. Similar results were observed in the cT1 and cTis subgroups. CONCLUSIONS: Greater extent of LND during RC for NMIBC is associated with improved LPRS, CSS and OS, supporting the inclusion of LND during RC for NMIBC, particularly among patients with cTis or cT1 disease. Future prospective studies are warranted to assess the ideal anatomical template of LND in NMIBC.
引用
- Khanna A, Miest T, Sharma V, et al. Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience. J Urol. 2021. PMID: 34694143. doi:10.1097/JU.0000000000002266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。